Boswellia Extract 500 mg
Goals
$12.76 $0.21 per serving
Product analysis
Boswellia Extract 500 mg combines boswellia and turmeric with their amounts and preparations identified for easier comparisons.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
Both herbal preparations are named, but their quality and absorption remain uncertain. Their presence alone does not establish an advantage over alternatives.
Ingredient Transparency100
Both ingredient amounts and preparations are disclosed. That makes comparisons with other boswellia and turmeric combinations straightforward.
Value For Money40
The turmeric portion contributes limited value in the serving comparison. Value for boswellia remains uncertain.
Customer Satisfaction90
Customer feedback is very positive. The substantial review base gives a useful picture of satisfaction.
Product Focus60
The two-ingredient combination keeps the formula relatively focused. Its fit with the intended goals appears moderate.
- Format
Capsule - Container
- 120 Capsule(s)
- Per serving
- $0.21
- Customer rating
- 4.7 · 9,998 ratings
Goals
Impact
Moderate effect
Boswellia · 500 mg
Boswellia at 500 mg is the main relevant ingredient, with a possible contribution through inflammation-related enzymes and joint comfort. Benefits in the supplied evidence depend on specific preparations studied in people with knee osteoarthritis; generic Boswellia and the accompanying 400 mg turmeric cannot be assumed to offer equivalent effects.
How this product is rated for Inflammation
Ingredient fit81
The relevant ingredients give a focused contribution to the goal. The relevant amounts provide a partial match to the supplied dose comparisons.
Goal fit
The relevant ingredients give a focused contribution to the goal.
Dose adequacy
The relevant amounts provide a partial match to the supplied dose comparisons.
Pathways12
COX and LOX enzyme inhibition is the main area of support, with limited coverage in the saved findings. The saved findings show limited reach across the different aspects of inflammation support.
Depth
COX and LOX enzyme inhibition is the main area of support, with limited coverage in the saved findings.
Breadth
The saved findings show limited reach across the different aspects of inflammation support.
Evidence35
Boswellia provides the strongest relevant human evidence at the assessed amount, although practical benefits depend on context. The assessed preparation was not matched to the preparation used in the supplied human evidence.
Evidence strength
Boswellia provides the strongest relevant human evidence at the assessed amount, although practical benefits depend on context.
Studied preparation
The assessed preparation was not matched to the preparation used in the supplied human evidence.
Formulation logic100
The assessed ingredients can contribute on their own or have their required partner present. No ingredient conflicts were identified in the saved assessment. All assessed ingredients met the saved minimum amount criterion.
Partner coverage
The assessed ingredients can contribute on their own or have their required partner present.
Conflicts
No ingredient conflicts were identified in the saved assessment.
Effective doses
All assessed ingredients met the saved minimum amount criterion.
Impact
Moderate effect
Boswellia · 500 mg
Boswellia extract at 500 mg has a possible role in joint comfort through inflammatory processes. Evidence is specific to small, short trials of particular preparations; more extract does not establish cartilage repair or stronger symptom benefit. The separate 400 mg turmeric declaration is not a curcumin amount.
How this product is rated for Joint Health
Ingredient fit97
The relevant botanical provides a clear focus on the reviewed joint functions. The counted ingredient reaches the full saved amount comparison.
Goal fit
The relevant botanical provides a clear focus on the reviewed joint functions.
Dose adequacy
The counted ingredient reaches the full saved amount comparison.
Pathways40
The main mechanism in the saved assessment is inflammation control. One of the three target mechanisms reaches the saved coverage threshold.
Depth
The main mechanism in the saved assessment is inflammation control.
Breadth
One of the three target mechanisms reaches the saved coverage threshold.
Evidence30
Boswellia leads the saved evidence finding; normal function or an exposure match does not guarantee symptom improvement. The counted botanical lacks a confirmed match to the relevant studied preparation.
Evidence strength
Boswellia leads the saved evidence finding; normal function or an exposure match does not guarantee symptom improvement.
Studied preparation
The counted botanical lacks a confirmed match to the relevant studied preparation.
Formulation logic100
The counted ingredients can contribute independently or have their required partner. No configured ingredient conflict was found in the supplied assessment. 1 of 1 counted ingredients reach the saved minimum amount criterion.
Partner coverage
The counted ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was found in the supplied assessment.
Effective doses
1 of 1 counted ingredients reach the saved minimum amount criterion.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Boswellin (Boswellia serrata Gum Resin Extract) | 500 mg | |
Turmeric Root Extract (Curcuminoids) | 200 mg | |
Turmeric, Powder | 200 mg |
Boswellia (Boswellia serrata Gum Resin Extract) · 500 mg OverallScore100
A serving lists 500 mg of Boswellia serrata gum resin extract, with a recorded 70% boswellic-acid figure. The amount and marker percentage provide useful details for comparison.
How this ingredient is rated
Composition and Label Disclosure100
The saved facts record 70% boswellic acids for Boswellia serrata gum resin extract.
Marker and Preparation Disclosure
A 70% boswellic-acid figure is recorded for the preparation.
Composition and Label Disclosure100
The serving records 500 mg of Boswellia serrata gum resin extract and a 70% boswellic-acid figure.
Boswellia Amount and Marker Disclosure
The amount and associated boswellic-acid percentage are recorded as 500 mg and 70%.
Commercial Price and Usability
A whole-product serving costs about $0.21; no separate price rule was evaluated.
Turmeric (Curcuminoids) · 200 mg OverallScore30
Each serving provides 200 mg turmeric root extract and 200 mg turmeric powder; the extract is declared at 95% curcuminoids. The stated percentage corresponds to 190 mg curcuminoids from the extract, while the powder’s curcuminoid amount is unknown.
How this ingredient is rated
Composition and Label Disclosure55
The 200 mg turmeric root extract is declared at 95% curcuminoids; no percentage is established for the 200 mg turmeric powder.
Declared Total Curcuminoid Concentration
The 200 mg turmeric root extract is declared at 95% curcuminoids; no percentage is established for the 200 mg turmeric powder.
Composition and Label Disclosure0
The extract’s stated percentage corresponds to 190 mg curcuminoids; the powder’s curcuminoid amount remains unknown.
Preparation and Marker Amount Disclosure
The extract’s stated percentage corresponds to 190 mg curcuminoids; the powder’s curcuminoid amount remains unknown.
Commercial Price and Usability40
A whole-product serving costs about $0.21.
Selected-Serving Price Comparison
A whole-product serving costs about $0.21.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
- A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
- Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
- A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
- A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
- Oral herbal therapies for treating osteoarthritis.
- Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
- A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.